Mometasonfuroat Puren (Mometasone Furoate)

Mometasone furoate, the active ingredient in Mometasonfuroat Puren, is a corticosteroid presented as a nasal spray for nasal administration. It reduces nasal inflammation and congestion associated with allergic rhinitis, seasonal or perennial, and nasal polyps in both adult and pediatric patients.

GNH USA supplies Mometasonfuroat Puren as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, providing consistent quality for global distribution and adhering to stringent regulatory standards with reliable supply‑chain solutions for healthcare providers.

Mometasone furoate nasal spray acts on the inflammatory pathways of the nasal mucosa to treat several allergic and inflammatory conditions.

Allergic rhinitis: reduces sneezing, itching, and nasal discharge. Seasonal allergic rhinitis: controls symptoms triggered by seasonal allergens. Perennial allergic rhinitis: maintains year‑round symptom relief. Nasal polyps: decreases polyp size and improves nasal airflow.

Mometasone furoate nasal spray may cause local and systemic adverse reactions.

Common Side Effects: - Nasal irritation or burning sensation - Epistaxis (nosebleed) - Headache - Throat irritation or dryness - Cough - Altered taste perception

Serious or Rare Side Effects: - Nasal septal perforation - Adrenal suppression with systemic effects - Cataracts or glaucoma - Fungal infection of the nasal passages - Severe allergic reaction (anaphylaxis) - Vision changes or ocular pressure increase

Before using Mometasone furoate nasal spray, consider the following precautions.

Pregnancy: consult a healthcare provider before use. Breastfeeding: assess risk versus benefit with a clinician. Pediatric use: follow pediatric dosing guidelines. Concurrent nasal decongestants: avoid prolonged combined use. Monitor for signs of adrenal insufficiency, especially with high‑dose or long‑term therapy. Store at room temperature: keep in the original container, protect from moisture and heat.

Mometasone furoate nasal spray can interact with other medicines; review the following categories.

Major Interactions (Avoid): - Systemic corticosteroids: increased risk of systemic glucocorticoid effects. - Strong CYP3A4 inhibitors (e.g., ketoconazole, itraconazole): may raise local drug exposure. - Live vaccines: potential reduction in vaccine efficacy.

Moderate Interactions (Monitor Closely): - Strong CYP3A4 inducers (e.g., rifampin, carbamazepine): may reduce effectiveness. - Other intranasal medications (e.g., antihistamine sprays): monitor for additive irritation. - Nasal decongestants used long‑term: watch for rebound congestion.